Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP485788.RAplduRZP3LgkFhIPN7HIwPMJ3qguA2v3K2wyBdSagjPQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP485788.RAplduRZP3LgkFhIPN7HIwPMJ3qguA2v3K2wyBdSagjPQ130_assertion type Assertion NP485788.RAplduRZP3LgkFhIPN7HIwPMJ3qguA2v3K2wyBdSagjPQ130_head.
- NP485788.RAplduRZP3LgkFhIPN7HIwPMJ3qguA2v3K2wyBdSagjPQ130_assertion description "[We have previously described that tissue transglutaminase (tTG) is a high level phenotypic biomarker in prostate cancer, which is down regulated in prostate cancer and surrounding premalignant field compared to benign prostate glands.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP485788.RAplduRZP3LgkFhIPN7HIwPMJ3qguA2v3K2wyBdSagjPQ130_provenance.
- NP485788.RAplduRZP3LgkFhIPN7HIwPMJ3qguA2v3K2wyBdSagjPQ130_assertion evidence source_evidence_literature NP485788.RAplduRZP3LgkFhIPN7HIwPMJ3qguA2v3K2wyBdSagjPQ130_provenance.
- NP485788.RAplduRZP3LgkFhIPN7HIwPMJ3qguA2v3K2wyBdSagjPQ130_assertion SIO_000772 16301118 NP485788.RAplduRZP3LgkFhIPN7HIwPMJ3qguA2v3K2wyBdSagjPQ130_provenance.
- NP485788.RAplduRZP3LgkFhIPN7HIwPMJ3qguA2v3K2wyBdSagjPQ130_assertion wasDerivedFrom befree-20140225 NP485788.RAplduRZP3LgkFhIPN7HIwPMJ3qguA2v3K2wyBdSagjPQ130_provenance.
- NP485788.RAplduRZP3LgkFhIPN7HIwPMJ3qguA2v3K2wyBdSagjPQ130_assertion wasGeneratedBy ECO_0000203 NP485788.RAplduRZP3LgkFhIPN7HIwPMJ3qguA2v3K2wyBdSagjPQ130_provenance.